NCT04490837

Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID)

Rapid Diagnostic Test for COVID-19 Based on Antibody Detection

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,500 (actual)
• Sponsor: Corporacion Parc Tauli · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Ycovid-19 aims to be a rapid diagnostic test for SARS-CoV-2 infection, which will allow a reliable diagnosis to be made in 10 minutes, and on easy-to-use devices. This test will be developed using innovative technology developed at the Parc Taulí University Hospital, which increases the immunogenicity of SARS-CoV-2 differential antigens. The increased immunogenicity of these antigens will allow to detect, with a high sensitivity and specificity, the antibodies in the serum of patients infected with SARS-CoV-2. This test will serve to confirm dubious results as well as reduce false negatives from the PCR test, which will ultimately help reduce transmission of the infection.

Conditions

• Covid-19

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	ELISA and Rapid test to detect antibodies against COVID-19	Ycovid-19 aims to be a rapid diagnostic test for SARS-CoV-2 infection, which will allow a reliable diagnosis to be made in 10 minutes, and on easy-to-use devices

Timeline

• Start date: 2020-06-22
• Primary completion: 2020-07-31
• Completion: 2020-09-30
• First posted: 2020-07-29
• Last updated: 2021-07-29

Locations

1 site across 1 country: Spain